Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients
Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients
About this item
Full title
Author / Creator
Publisher
Poland: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Poland: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The data on prevalence and clinical relevance of TP53 germline mutations in early onset Middle-Eastern breast cancer (BC) is limited.
We determined TP53 germline mutations in a cohort of 464 early onset BC patients from Saudi Arabia using capture sequencing based next generation sequencing.
Germline TP53 pathogenic mutations were found in 1.5...
Alternative Titles
Full title
Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_69aadafd781648d29b443baea330bfaf
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_69aadafd781648d29b443baea330bfaf
Other Identifiers
ISSN
1731-2302,1897-4287
E-ISSN
1897-4287
DOI
10.1186/s13053-021-00206-w
